ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Diagnosing and Treating Depression in Head and Neck Cancer Patients

by Mary Beth Nierengarten • August 7, 2018

  • Tweet
  • Email
Print-Friendly Version

Among the many challenges facing patients with head and neck cancer, depression can be an added stressor that, if unrecognized and untreated, contributes to decreased quality of life and early mortality.

You Might Also Like

  • Depression Affects Two-Year Survival Rates in Head and Neck Cancer Patients
  • Otolaryngologists Can Play Vital Role in Helping Patients Manage Depression
  • Depression, Anxiety Rarely Assessed in Patients with Otolaryngologic Disorders
  • How Tumor Boards Can Improve Care for Patients with Head, Neck Cancer
Explore This Issue
August 2018

This information is not new. Evidence has long shown that depression rates in cancer patients are among the highest in those with head and neck cancers, occurring in approximately 15% to 50% of these patients. Some of these patients will present with or have a prior history of depression, while others will develop depression in the year following diagnosis. For patients who do develop depression, symptoms typically peak two to three months after diagnosis (Cancer Epidemiol. 2016;43:42-48; Clin Adv Hematol Oncol. 2009;7:397-403).

Recognizing the increased risk for and prevalence of depression in head and neck patients is the first critical step in addressing the problem. Diagnosis can be tricky, however, because many of the symptoms of depression are similar to side effects of cancer treatment. Additionally, treatment may be unfamiliar territory for clinicians who don’t typically address behavioral health issues.

Although diagnosing and treating depression may not be considered a part of standard otolaryngologic care, the high rates of depression in head and neck patients and associated decrease in quality of life and survival make it imperative that physicians address this issue more effectively.

“Looking at historical norms, we don’t do a very good job of addressing depression in our patients,” said William M. Lydiatt, MD, chair in the department of surgery at Nebraska Methodist Hospital and clinical professor of surgery at Creighton University in Omaha, who has written extensively on the issue. This lack in addressing depression occurs not only because otolaryngologists and other members of a typical treatment team (i.e., radiation oncologists and medical oncologists) lack the training and facility to diagnose it, said Dr. Lydiatt, but also because it is an issue that patients themselves don’t want to address. “Many patients just don’t want to address one more thing,” he said.

One way to better address this issue is to include a behavioral therapist in the treatment team to ensure that depression is identified early and treated appropriately. Another strategy suggested by recent data is the prophylactic use of antidepressants as part of the treatment protocol for all head and neck patients, particularly for those at high risk of depression.

Although there is currently no standard approach to address depression in these patients, what is clear is the need to do so and to address it with more success. “Depression is common and impacts quality of life and survival,” said Dr. Lydiatt. “It can be treated or prevented in many cases.”

Need to Address All Depression, Even Mild Cases

The substantial effect depression can have on these patients is underscored by ongoing data showing their reduced survival rates due to the depression. A study published in 2018 confirmed this evidence, showing that depressive symptoms predicted shortened survival among patients with head and neck cancer (Cancer. 2018;124:1053-1060).

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider Tagged With: depression, head and neck cancerIssue: August 2018

You Might Also Like:

  • Depression Affects Two-Year Survival Rates in Head and Neck Cancer Patients
  • Otolaryngologists Can Play Vital Role in Helping Patients Manage Depression
  • Depression, Anxiety Rarely Assessed in Patients with Otolaryngologic Disorders
  • How Tumor Boards Can Improve Care for Patients with Head, Neck Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
    • How 3D Printing Is Transforming the Pediatric Otolaryngology Field
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.